Related Experiment Video
Updated: May 4, 2026

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Multiple roles of bile acids in ferroptosis regulation: Opportunities for disease therapy
Nan Wu1, Shuang Yu1, Xiaoqi Wei1
1Department of Central Laboratory, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, PR China.
Abstract:
Bile acids (BAs), the main component of bile, play a key role in the digestion of lipids. However, recent studies have demonstrated that BAs can also act as signaling molecules, regulating metabolism by binding to BA receptors. Ferroptosis is an iron-dependent form of cell death characterized by lipid peroxidation, and it is closely associated with lipid and iron metabolism. Recent studies have shown that BA levels are significantly correlated with ferroptosis in certain diseases, including liver and gallbladder diseases, colitis, tumors, and infectious diseases. However, the effect of BAs on ferroptosis varies. Some BAs, such as deoxycholic acid (DCA), glycochenodeoxycholic acid (GCDCA), and ursodeoxycholic acid (UDCA), can trigger cellular oxidative stress, which, in turn, induces ferroptosis. While other BAs, such as taurolithocholic acid (TLCA) and tauroursodeoxycholic acid (TUDCA), significantly inhibit ferroptosis, thereby attenuating cell and tissue damage. To our knowledge, this review is the first to systematically summarize the roles and mechanisms of BAs in regulating ferroptosis under different disease conditions. Potential therapeutic methods and clinical applications have also been proposed for targeting BA-mediated ferroptosis in various diseases, providing guidance for subsequent research on BAs and ferroptosis.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Lysosomal Hydrolases
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
